Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00919100|
Recruitment Status : Completed
First Posted : June 12, 2009
Results First Posted : September 18, 2018
Last Update Posted : November 21, 2018
|Condition or disease||Intervention/treatment||Phase|
|Pain||Device: Buzzy Other: vapocoolant||Not Applicable|
Needle pain is the most common and the most feared source of childhood pain, resulting in needle phobia for 10% of adults. Current pain relief options include numbing creams, vapocoolant spray, or injected lidocaine. 17 million pediatric IV access procedures are done yearly with no pain intervention. An inexpensive, immediately acting form of needle pain control could reduce needle phobia in the long term if demonstrated to be effective for needle pain.
This study will evaluate pain self report and parent report using the Faces Pain Scale revised, and video-coded OSBD-R scores for patients undergoing emergency department venous access or cannulation procedures. Demographic information, pre-procedural anxiety, and success data from the attempts at placement will be included.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||81 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Buzzy: An Integration of Vibration, Cold, and Distraction for Pediatric Needle Pain Relief|
|Study Start Date :||April 2008|
|Actual Primary Completion Date :||August 2008|
|Actual Study Completion Date :||August 2008|
venipuncture with vapocoolant spray offered
venipuncture with vapocoolant spray offered
Other Name: PainEase
Vibrating device with cold pack held to arm with tourniquet proximal to venipuncture site, optional distraction cards.
"Buzzy" is a vibrating cold pack attached with Velcro strap or tourniquet 5-10cm proximal to the site of venipuncture. The vibration is activated and the device remains in place throughout the procedure. The distraction cards are offered to the parents to show the children, with questions on the back and pictures on the front.
Other Name: BuzzyR
- Faces Pain Scale-Revised (FPS-R) [ Time Frame: 5 minute ]Self-report measure of pain via 6 faces ranging from neutral to increasing pain expression. The scoring for the scale ranges from 0-10 with lower scores representing lower pain and higher scores representing higher pain. The FPS-R was conducted several minutes following venipuncture. This time was not tracked, but it was typically between 2-5 minutes following completion of the venipuncture.
- OSBD-R Observational Pain/Distress Scale [ Time Frame: 5 minute ]The Observational Scale of Behavioral Distress (OSBD) is a validated and commonly used scale. There are 11 OSBD distress responses (information seeking, cry, scream, physical restraint, verbal resistance, seeking emotional support, verbal pain, flail, verbal fear, muscular rigidity, and nervous behavior). Using videotapes of the venipuncture, a composite OSBD score of 1 (low distress) to 11 (high distress) was assigned from the time of placement of tourniquet to placement of the bandage or securing the intravenous line (IV) after the first attempt. Two students not associated with the hospital or the device had been previously trained in this methodology and coded all tapes. A supervisor assessed interrater reliability on each coded behavior. After each group of 10 subjects, interrater agreements that fell below the level of excellent agreement (kappa = 0.80) were reviewed and discussed by both coders, with the consensus score recorded and definitions of observed behaviors.
- Number of Participants With Venipuncture Success in One Attempt [ Time Frame: 5 minutes ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00919100
|United States, Georgia|
|Children's Healthcare of Atlanta, Scottish Rite|
|Atlanta, Georgia, United States, 30342|
|Principal Investigator:||Amy L Baxter, MD||Children's Healthcare of Atlanta|
|Principal Investigator:||Lindsey L Cohen, PhD||Georgia State University|